One of the objectives of the 2017 National Prevalence Survey (ENP) was to measure and describe the prevalence of patients treated with antibiotics in healthcare facilities and to compare...

Introduction - Cardiovascular diseases (CVD) and stroke are responsible for more than 200,000 deaths each year in France. Few recent studies have described the French population’s...

Introduction - Myocardial infarction (MI) is a major cause of morbidity and mortality in France. Early recognition of MI symptoms and calling the Emergency Medical Services (EMS) are...

Introduction - Cardiovascular diseases (CVD) are the second leading cause of death in France and the third leading cause of premature death. The objective of our study was to describe...

The purpose of external reporting of healthcare-associated infections (HAIs) is to identify situations involving a risk of infection that require the implementation of control measures....

Saint-Pierre-et-Miquelon is a French overseas territory in North America, with a population of 6,008 in 2016, where the Territorial Health Administration (ATS) exercises the powers...

Testing is the weak link in the HIV care pathway in France. Despite new recommendations and a broader range of testing options, the increase in the number of tests is not enough to...

Introduction - Since July 1, 2019, the "Au labo sans ordo" (ALSO) program has offered free, prescription-free HIV testing in all private medical laboratories in Paris and the...

Introduction - The CeGIDDs (free centers for information, screening, and diagnosis of human immunodeficiency virus (HIV) infections, viral hepatitis, and bacterial sexually transmitted...